Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Bioelectronics News

    0,0002 $ 0,00% +0,00 $
    In : 0,0002 € | 17:44:38 Uhr Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A0J2WS
    ISIN: US09062H1086
    US-Symbol: BIEL
    Typ: Aktie

    Bioelectronics News

    06.11.20 - PR Newswire
    BioElectronics' ActiPatch® Therapy To Be Marketed By DonJoy® Advantage
    BioElectronics' ActiPatch® Therapy To Be Marketed By DonJoy® Advantage Drug-Free Pain Relief Technology with Premium Wraps PR Newswire
    10.07.19 - ACCESSWIRE
    The Stock Day Podcast Hosts BioElectronics' to Discuss Its New Technology To Mitigate Opioid Use
    PHOENIX, AZ / ACCESSWIRE / July 10, 2019 / The Stock Day Podcast welcomed BioElectronics Corporation (BIEL) (“the Company”), a leader in non-​invasive electroceuticals and the ...
    14.03.19 - PR Newswire
    Northwest Specialty Hospital Now Offering Electroceutical Alternative To Opioids In Clinical Practice
    Northwest Specialty Hospital Now Offering Electroceutical Alternative To Opioids In Clinical Practice PR Newswire
    13.11.18 - ACCESSWIRE
    BioElectronics Discusses Advancing the Electroceuticals Market
    PHOENIX, AZ/ ACCESSWIRE / November 13th, 2018 / BioElectronics Corporation (OTC PINK: BIEL), is a maker of advanced medical devices. Nalepka, VP of Sales and Marketing, ...
    10.10.16 - PR Newswire
    BioElectronics Comments on its U.S. FDA's OTC Market Clearance Application
    BioElectronics Comments on its U.S. FDA's OTC Market Clearance Application PR Newswire
    03.10.16 - PR Newswire
    BioElectronics' ActiPatch® Drug-free Pain Therapy to be Featured at Pharmacy Week in Trinidad & Tobago W.I.
    BioElectronics' ActiPatch® Drug-free Pain Therapy to be Featured at Pharmacy Week in Trinidad & Tobago W.I. PR Newswire
    28.09.16 - PR Newswire
    BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication
    BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication PR Newswire
    11.05.16 - PR Newswire
    BioElectronics Engages Adam Staelin As Executive Vice President of Sales and Marketing
    BioElectronics Engages Adam Staelin As Executive Vice President of Sales and Marketing PR Newswire
    10.05.16 - PR Newswire
    BioElectronics Responds to U.S. FDA's Comments on its Market Clearance Application
    BioElectronics Responds to U.S. FDA's Comments on its Market Clearance Application PR Newswire
    28.04.16 - PR Newswire
    BioElectronics' Drug-free ActiPatch® Pain Therapy
    BioElectronics' Drug-free ActiPatch® Pain Therapy Highlighted in UK's Express Newspaper on Dangers of Excessive Drug Use PR Newswire
    25.04.16 - PR Newswire
    BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section
    BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section PR Newswire
    11.04.16 - PR Newswire
    BioElectronics President Interviewed by the StockRadio.com
    BioElectronics President Interviewed by the StockRadio.com Discusses Bioelectronics Mitigation of Chronic Pain and Drug Use PR Newswire
    29.03.16 - PR Newswire
    BioElectronics Drug-free Chronic Pain Therapy Observation Study Results
    BioElectronics Drug-free Chronic Pain Therapy Observation Study Results 61% Pain Reduction & Decreases Medication Use in 86% (including opioids) PR Newswire
    21.03.16 - PR Newswire
    BioElectronics Appoints Evomed as Australian and New Zealand Distributor
    BioElectronics Appoints Evomed as Australian and New Zealand Distributor PR Newswire
    15.03.16 - PR Newswire
    BioElectronics Wins "Best OTC Marketing Campaign on a Small Budget"
    BioElectronics Wins "Best OTC Marketing Campaign on a Small Budget" PR Newswire
    09.03.16 - PR Newswire
    BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress
    BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress PR Newswire
    18.02.16 - PR Newswire
    BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff
    BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff PR Newswire
    08.02.16 - PR Newswire
    BioElectronics Corporation Refutes SEC Order for Administrative Proceedings
    BioElectronics Corporation Refutes SEC Order for Administrative Proceedings PR Newswire
    05.01.16 - PR Newswire
    BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis
    BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis PR Newswire
    14.12.15 - PR Newswire
    BioElectronics Announces Oxford University Sponsored Study
    BioElectronics Announces Oxford University Sponsored Study ActiPatch® Therapy for Chronic Low Back Pain PR Newswire

    Newssuche

    Videos

    09:10 Uhr -3,23%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »